PainChek Limited (PCK)
CXA CXA Primary Summary
PainChek Limited (PCK) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has PainChek Limited ever had a stock split?
PainChek Limited Profile
| Insurance Industry | Financials Sector | Mr. Philip Daffas B.Sc., Dip EENG, GAICD, M.B.A. CEO | CXA Exchange | - ISIN |
| Australia Country | - Employees | - Last Dividend | 27 Nov 2025 Last Split | - IPO Date |
Overview
PainChek Limited, formerly known as ePAT Technologies Ltd, is a pioneering company based in Sydney, Australia, focused on the development and commercialization of advanced mobile medical device applications. With a global operational reach, the company is dedicated to enhancing pain assessment procedures, particularly for individuals unable to communicate their pain effectively, such as those suffering from dementia and pre-verbal infants. The transition from ePAT Technologies Ltd to PainChek Limited in January 2018 signifies the company's dedicated focus on pain assessment technology and its commitment to providing innovative solutions to critical healthcare challenges.
Products and Services
- PainChek
The flagship product of PainChek Limited, PainChek, is a revolutionary mobile application that employs the camera of smartphones and tablets to perform real-time facial scans. These scans are then analyzed using sophisticated facial recognition software, which interprets facial expressions to indicate the presence and intensity of pain. This technology offers a groundbreaking approach to pain assessment for individuals who are unable to verbally communicate their pain, such as those with dementia or pre-verbal infants. By integrating advanced technology with everyday devices, PainChek is setting new standards in patient care and pain management.
